Ethylene diamine functionalized MIL‐101(Cr) was established to be an efficient organocatalyst for single‐pot synthesis of polyhydroquinolines via four‐component condensation reaction between aldehydes, dimedone, β‐ketoecters and ammonium acetate in aqueous medium. Ethylene diamine of the parent open metal site MIL‐101(Cr) has been carried out through a post‐synthetic modification (PSM) technique. Efficient transformation, mild condition, easy product isolation and the potential high recycbility of the organocatalyst are the key feature of this protocol.
Fabrication of a nanocomposite catalyst via a novel and efficient strategy remains a challenge; Fe 3 O 4 nanoparticles anchored on graphene oxide (GO) sheet-supported metal-organic frameworks (MOFs). In this study, the physicochemical properties of the ensuing Fe 3 O 4 /Cu-BDC/GO are investigated using Fourier transform infrared spectrum, scanning electron microscopy, transmission electron microscopy, X-ray photoelectron spectroscopy, energy-dispersive X-ray detector, and atomic absorption spectroscopy. The salient features of the nanocomposite such as Cu-MOF, synergistic effect with GO sheets, and magnetic separation characteristics make it an excellent ternary heterostructure for aerobic oxidation of alcohols. The proposed nanocatalyst and co-catalyst 2,2,6,6-tetramethylpiperidine-N-oxyl substantially enhance the catalytic performance for the aerobic oxidation under very mild and sustainable reaction conditions. The heterogeneity of Fe 3 O 4 /Cu-BDC/GO composite catalyst is affirmed with the added advantage that the initial activity is well maintained even after seven cycles.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.